• Science & Technology

An AI test to help guide bowel cancer treatment

A new AI test that looks at immune cells could help people with stage 2 bowel cancer avoid chemotherapy after surgery, cutting side effects. A new AI test that looks at immune cells could help people with stage 2 bowel cancer avoid chemotherapy after surgery, cutting side effects.

27 January 2025

• Science & Technology

Fighting fire with fire: could Salmonella treat bowel cancer?

Our researchers are modifying Salmonella bacteria into a treatment that can work with the immune system to attack bowel cancer from two sides at once. Our researchers are modifying Salmonella bacteria into a treatment that can work with the immune system to attack bowel cancer from two sides at once.

23 January 2025

• Science & Technology

£10m funding for new programme to help identify individual cancer risk

Today, Cancer Research UK, the National Institute for Health and Care Research (NIHR) and the Engineering and Physical Sciences Research Council (EPSRC) are announcing £10 million to create the Cancer Data-Driven Detection programme, which aims to use data to identify individual cancer risk. Today, Cancer Research UK, the National Institute for Health and Care Research (NIHR) and the Engineering and Physical Sciences Research Council (EPSRC) are announcing £10 million to create the Cancer Data-Driven Detection programme, which aims to use data to identify individual cancer risk.

22 January 2025

• Science & Technology

Southampton scientists switch focus and make key discovery that could make immunotherapy more effective

A bold change of approach by our scientists investigating what prevents immunotherapy from working in a large number of patients has led to a significant discovery that could improve outcomes across multiple cancers. A bold change of approach by our scientists investigating what prevents immunotherapy from working in a large number of patients has led to a significant discovery that could improve outcomes across multiple cancers.

7 January 2025

• Science & Technology
• Health & Medicine

The ‘year of cancer vaccines’ confirms we are living in a golden age of cancer research

Michelle Mitchell reflects on how the growing promise of cancer vaccines shows that we are living in a golden age of cancer research Michelle Mitchell reflects on how the growing promise of cancer vaccines shows that we are living in a golden age of cancer research

30 December 2024

• Science & Technology
• Health & Medicine
• Charity News

Getting ahead of cancer: our 2024 research highlights

The advances we made in 2024 are helping turn cancer from a disease doctors diagnose and treat to one we can seek out and stop. Here are some of our biggest stories from the past 12 months. The advances we made in 2024 are helping turn cancer from a disease doctors diagnose and treat to one we can seek out and stop. Here are some of our biggest stories from the past 12 months.

17 December 2024

• Science & Technology

World-first urine test for lung cancer picks out 'zombie' cells

With our funding, scientists in Cambridge have created a urine test that can detect some of the first signs of lung cancer. With our funding, scientists in Cambridge have created a urine test that can detect some of the first signs of lung cancer.

6 December 2024

• Science & Technology

Could a chemical found in red grapes prevent bowel cancer?

Scientists funded by Cancer Research UK are finding out if an ingredient commonly found in red grapes could help prevent bowel cancer. Scientists funded by Cancer Research UK are finding out if an ingredient commonly found in red grapes could help prevent bowel cancer.

11 November 2024

• Health & Medicine
• Science & Technology

NICE recommends elranatamab for adults with a rare form of blood cancer

The National Institute for Health and Care Excellence (NICE) has recommended the use of elranatamab for adults with multiple myeloma, a cancer that forms in a type of white blood cell called a plasma cell. The National Institute for Health and Care Excellence (NICE) has recommended the use of elranatamab for adults with multiple myeloma, a cancer that forms in a type of white blood cell called a plasma cell.

1 November 2024

• Science & Technology

Can we use AI to help our immune systems fight cancer?

With help from a new Nobel Laureate, Cancer Grand Challenges team MATCHMAKERS are developing AI models that can identify the immune cells best equipped to fight different cancers. That should make it possible to improve immunotherapies and match patients with the treatments best suited to them as individuals. With help from a new Nobel Laureate, Cancer Grand Challenges team MATCHMAKERS are developing AI models that can identify the immune cells best equipped to fight different cancers. That should make it possible to improve immunotherapies and match patients with the treatments best suited to them as individuals.

31 October 2024